These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31407195)

  • 1. Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial.
    Baram SM; Karima S; Shateri S; Tafakhori A; Fotouhi A; Lima BS; Rajaei S; Mahdavi M; Tehrani HS; Aghamollaii V; Aghamiri SH; Mansouri B; Gharahje S; Kabiri S; Hosseinizadeh M; Shahamati SZ; Alborzi AT
    Inflammopharmacology; 2019 Dec; 27(6):1101-1112. PubMed ID: 31407195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflawell
    Barzin Tond S; Balenci L; Khajavirad N; Salehi M; Tafakhori A; Shahmohammadi MR; Ghiasvand F; Jafari S; Abolghasemi S; Mokhtari F; Mahmoodi Baram S; Zarei T; Kazemi D; Mohammadnejad E; Shah-Hosseini A; Haghbin Toutounchi A; Fallah S; Riazi A; Karima S
    Inflammopharmacology; 2022 Apr; 30(2):465-475. PubMed ID: 35201518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
    Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boswellic Acids and Their Role in Chronic Inflammatory Diseases.
    Ammon HP
    Adv Exp Med Biol; 2016; 928():291-327. PubMed ID: 27671822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
    Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the immune system by Boswellia serrata extracts and boswellic acids.
    Ammon HP
    Phytomedicine; 2010 Sep; 17(11):862-7. PubMed ID: 20696559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Kirste S; Treier M; Wehrle SJ; Becker G; Abdel-Tawab M; Gerbeth K; Hug MJ; Lubrich B; Grosu AL; Momm F
    Cancer; 2011 Aug; 117(16):3788-95. PubMed ID: 21287538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
    Bornstein NM; Saver JL; Diener HC; Gorelick PB; Shuaib A; Solberg Y; Thackeray L; Savic M; Janelidze T; Zarqua N; Yarnitsky D; Molina CA;
    Lancet; 2019 Jul; 394(10194):219-229. PubMed ID: 31133406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia.
    Zeng L; Wang Y; Liu J; Wang L; Weng S; Chen K; Domino EF; Yang GY
    Neurosci Lett; 2013 Aug; 548():4-9. PubMed ID: 23643982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
    Emsley HC; Smith CJ; Gavin CM; Georgiou RF; Vail A; Barberan EM; Illingworth K; Scarth S; Wickramasinghe V; Hoadley ME; Rothwell NJ; Tyrrell PJ; Hopkins SJ
    BMC Neurol; 2007 Feb; 7():5. PubMed ID: 17328808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.
    Licata G; Tuttolomondo A; Di Raimondo D; Corrao S; Di Sciacca R; Pinto A
    Thromb Haemost; 2009 May; 101(5):929-37. PubMed ID: 19404547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial.
    Liu X; Xia J; Wang L; Song Y; Yang J; Yan Y; Ren H; Zhao G
    Eur J Neurol; 2009 May; 16(5):569-75. PubMed ID: 19236467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial.
    de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E
    Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.
    Muscari A; Puddu GM; Santoro N; Serafini C; Cenni A; Rossi V; Zoli M
    Clin Neuropharmacol; 2011; 34(4):141-7. PubMed ID: 21677574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial.
    Mohammadianinejad SE; Majdinasab N; Sajedi SA; Abdollahi F; Moqaddam MM; Sadr F
    Clin Neuropharmacol; 2014; 37(3):73-8. PubMed ID: 24824661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.